Additional investigation into DLAT expression in different BC subcategories revealed relatively elevated DLAT expression levels in TNBC compared to hormone receptor-positive and HER2-positive BC subtypes (Figure 1b). This evidence concerns the gene ERBB2 and breast cancer.